Professional Documents
Culture Documents
• Laggard share price likely to follow. From August-to-date, the share price
1,410 113
1,210 95
of other construction SOE peers have rallied 29-56%, on the back of
optimism in construction activity improvement in 2H21. However, WSKT’s 1,010 78
share price is still down 10%, which we believe is caused by investor 810 61
concerns on its debt condition and attractiveness of the rights issuance. 610 44
May-21
May-21
Feb-21
Mar-21
Mar-21
Apr-21
Apr-21
Jul-21
Dec-20
Dec-20
Oct-21
Oct-21
Nov-21
Jan-21
Jan-21
Jun-21
Jun-21
Aug-21
Aug-21
Sep-21
Sep-21
Nov-21
After the corporate action is completed, investor confidence in the company
is likely to improve – providing the highest upside among its peers.
Source: Bloomberg
• Earnings revision. We revise our FY22F earnings from booking a loss of
IDR143bn to a profit of IDR24bn despite of lower operational performance
by 12.2%, as financing cost eases from debt restructuring and asset
recycling in 2021.
• ESG. We raise our ESG score of 2.7 from 2.3 out of 4.0 for the stock,
applying a 6% discount to our intrinsic value to derive our TP, as WSKT has
successfully lightened its balance sheet and has plans to improve its risk Overall ESG Score: 2.70 (out of 4)
management.
E: GOOD
• Main risk lies with its project execution – if the Government tightens activity WSKT plays an active role in Green Building Council
restrictions after the year-end festivities. Indonesia (GBCI), and participates in the Government’s
Tree Planting Movement. However, its projects are heavily
focused on the toll road segment, and therefore, it is
involved in changing the country’s landscape. It also
requires heavy equipment, which emit greenhouse gases.
S: GOOD
It implements ISO 9001:2008, ISO 14001: 2004, OHSAS
Forecasts and Valuation Dec-19 Dec-20 Dec-21F Dec-22F Dec-23F 18001: 2007, in relation to safety and health. The standards
Total turnover (IDRb) 31,387 16,190 16,583 22,807 27,994 are used to monitor and evaluate the health and safety
Recurring net profit (IDRb) 72 (6,300) (3,486) (1,040) 129
protocols applied to all stakeholders that enter the
company’s workplace (headquarters and site offices).
Recurring net profit growth (%) (96.6) (8,845.1) (44.7) (70.2) -
During the pandemic, it allocated an additional budget for
Recurring P/E (x) 150.74 na na na 236.80 regular COVID-19 testing to ensure the safety of its
P/B (x) 0.6 1.6 1.6 1.4 1.4 workers.
P/CF (x) 1.01 16.47 23.88 na 6.33 G: GOOD
The company has successfully completed debt Master
Dividend Yield (%) 9.1 na na na na
Restructuring Agreement (MRA) of IDR29.2trn, and
EV/EBITDA (x) 4.88 na 11.80 11.26 7.00 divested four assets in 2021 to improve its balance sheet
Return on average equity (%) 5.5 (61.7) 0.9 0.1 0.6 condition. Going forward, company plans to improve its
Net debtcover
Interest to equity
(x) (%) 211.6
1.09 384.4
(0.91) 148.5
0.24 97.8
0.66 71.6
1.16 decision-making process based on risk management.
Source: Company data, RHB
Financial Exhibits
Asia Financial summary (IDR) Dec-19 Dec-20 Dec-21F Dec-22F Dec-23F
Indonesia Recurring EPS 5.31 (464.11) (134.82) (27.26) 3.38
Construction & Engineering DPS 72.98 - - - -
Waskita Karya BVPS 1,262.90 498.50 492.60 571.89 575.27
WSKT IJ Return on average equity (%) 5.5 (61.7) 0.9 0.1 0.6
Buy
Valuation metrics Dec-19 Dec-20 Dec-21F Dec-22F Dec-23F
Recurring P/E (x) 150.74 na na na 236.80
Valuation basis
P/B (x) 0.6 1.6 1.6 1.4 1.4
Our DCF assumptions include: i) WACC of 11.5%; ii) FCF Yield (%) 79.5 7.2 (0.4) (10.6) 12.0
3% long-term growth
Dividend Yield (%) 9.1 - - - -
EV/EBITDA (x) 4.88 na 11.80 11.26 7.00
Key drivers
EV/EBIT (x) 5.63 na 23.37 17.55 9.68
Our FY20 forecasts are most sensitive to changes in:
i. Operating cash flow collection; Income statement (IDRb) Dec-19 Dec-20 Dec-21F Dec-22F Dec-23F
ii. Completion of turnkey projects;
Total turnover 31,387 16,190 16,583 22,807 27,994
iii. Higher toll road traffic volume;
Gross profit 5,314 (2,627) 2,223 3,111 4,223
iv. Toll road assets divestment;
v. New contracts obtained. EBITDA 4,544 (3,609) 1,684 2,560 3,646
Depreciation and amortisation (601) (720) (834) (917) (1,009)
Key risks Operating profit 3,943 (4,329) 850 1,643 2,637
Net interest (2,663) (3,991) (3,437) (1,866) (1,755)
The downside risks include:
i. Higher-than-expected financing costs; Pre-tax profit 2,035 (9,372) 689 752 883
ii. Delays in construction projects; Taxation (1,006) (123) (485) (598) (624)
iii. Delays in land acquisition. Reported net profit 938 (7,379) 121 24 129
Recurring net profit 72 (6,300) (3,486) (1,040) 129
Company Profile
Waskita Karya is a general contractor engaged in a Cash flow (IDRb) Dec-19 Dec-20 Dec-21F Dec-22F Dec-23F
diverse range of construction activities, such as roads, Change in working capital 9,821 9,690 (199) (3,698) 3,189
harbours, airports, buildings, sewerages, factories, and Cash flow from operations 10,804 659 866 (2,192) 4,818
other industrial facilities. The company also engages in Capex (2,173) 125 (947) (1,042) (1,146)
the precast concrete, realty, and energy businesses. In Cash flow from investing activities (16,750) (448) 7,313 3,148 (239)
addition, it has some investments in toll road projects. Dividends paid (991) (47) 0 0 0
Cash flow from financing activities 4,359 (8,257) (1,926) (2,010) (1,747)
Cash at beginning of period 10,846 9,258 1,213 7,467 6,412
Net change in cash (1,587) (8,045) 6,253 (1,055) 2,832
Ending balance cash 9,258 1,213 7,466 6,412 9,244
Margin
(IDRbn)
PV of TV 78,172
ESG discount 6%
% of Equity 30%
Beta 1.80
Liquidity Premium 5%
Ke 23.4%
WACC 11.5%
TG 3%
Recommendation Chart
Date Recommendation Target Price Price
Price Close
2021-07-12 Neutral 960 870
3,200 Recommendations & Target Price
2021-04-15 Buy 1,200 1,020
na
4,000
2,700
1,460
940
630
1,400
2,000
1,200
960
2,700 2021-01-12 Buy 2,000 1,660
580
880
2020-11-26 Buy 1,400 1,055
2,200 2020-08-04 Neutral 630 600
2020-07-07 Buy 880 710
1,700
2020-06-14 Buy 940 730
200 Buy Neutral Sell Trading Buy Take Profit Not Rated Source: RHB, Bloomberg
Dec-16 Mar-18 Jun-19 Sep-20
Source: RHB, Bloomberg
3.0
2.3 2.3
2.0
1.0
0.0
Source: RHB
6
member of the Stock Exchange of Thailand. The Thai Institute of Directors Association 1. RHBIB does not have a financial interest in the securities or other capital market
has disclosed the Corporate Governance Report of Thai Listed Companies made products of the subject company(ies) covered in this report.
pursuant to the policy of the Securities and Exchange Commission of Thailand. RHB 2. RHBIB is not a market maker in the securities or capital market products of the
Securities (Thailand) PCL does not endorse, confirm nor certify the result of the Corporate subject company(ies) covered in this report.
Governance Report of Thai Listed Companies. 3. None of RHBIB’s staff or associated person serve as a director or board member*
of the subject company(ies) covered in this report
Indonesia *For the avoidance of doubt, the confirmation is only limited to the staff of research
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. This department
research does not constitute an offering document and it should not be construed as 4. RHBIB did not receive compensation for investment banking or corporate finance
an offer of securities in Indonesia. Any securities offered or sold, directly or indirectly, services from the subject company in the past 12 months.
in Indonesia or to any Indonesian citizen or corporation (wherever located) or to any 5. RHBIB did not receive compensation or benefit (including gift and special cost
Indonesian resident in a manner which constitutes a public offering under Indonesian arrangement e.g. company/issuer-sponsored and paid trip) in relation to the
laws and regulations must comply with the prevailing Indonesian laws and regulations. production of this report.
Singapore Thailand
This report is issued and distributed in Singapore by RHB Bank Berhad (through its Save as disclosed in the following link RHB Research conflict disclosures – Dec 2021
Singapore branch) which is an exempt capital markets services entity and an exempt and to the best of our knowledge, RHB Securities (Thailand) PCL hereby declares that:
financial adviser regulated by the Monetary Authority of Singapore. RHB Bank Berhad 1. RHB Securities (Thailand) PCL does not have a financial interest in the securities
(through its Singapore branch) may distribute reports produced by its respective or other capital market products of the subject company(ies) covered in this report.
foreign entities, affiliates or other foreign research houses pursuant to an arrangement 2. RHB Securities (Thailand) PCL is not a market maker in the securities or capital
under Regulation 32C of the Financial Advisers Regulations. Where the report is market products of the subject company(ies) covered in this report.
distributed in Singapore to a person who is not an Accredited Investor, Expert Investor 3. None of RHB Securities (Thailand) PCL’s staff or associated person serve as a
or an Institutional Investor, RHB Bank Berhad (through its Singapore branch) accepts director or board member* of the subject company(ies) covered in this report
legal responsibility for the contents of the report to such persons only to the extent 1. *For the avoidance of doubt, the confirmation is only limited to the staff of research
required by law. Singapore recipients should contact RHB Bank Berhad (through its department
Singapore branch) in respect of any matter arising from or in connection with the report. 4. RHB Securities (Thailand) PCL did not receive compensation for investment
banking or corporate finance services from the subject company in the past 12
United States months.
This report was prepared by RHB is meant for distribution solely and directly to “major” 5. RHB Securities (Thailand) PCL did not receive compensation or benefit (including
U.S. institutional investors as defined under, and pursuant to, the requirements of Rule gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in
15a-6 under the U.S. Securities and Exchange Act of 1934, as amended (the relation to the production of this report.
“Exchange Act”) via a registered U.S. broker-dealer as appointed by RHB from time to
time. Accordingly, any access to this report via Bursa Marketplace or any other Indonesia
Electronic Services Provider is not intended for any party other than “major” US Save as disclosed in the following link RHB Research conflict disclosures – Dec 2021
institutional investors (via a registered U.S broker-dealer), nor shall be deemed as and to the best of our knowledge, PT RHB Sekuritas Indonesia hereby declares that:
solicitation by RHB in any manner. RHB is not registered as a broker-dealer in the 1. PT RHB Sekuritas Indonesia and its investment analysts, does not have any
United States and currently has not appointed a U.S. broker-dealer. Additionally, RHB interest in the securities of the subject company(ies) covered in this report.
does not offer brokerage services to U.S. persons. Any order for the purchase or sale For the avoidance of doubt, interest in securities include the following:
of all securities discussed herein must be placed with and through a registered U.S. a) Holding directly or indirectly, individually or jointly own/hold securities or
broker-dealer as appointed by RHB from time to time as required by the Exchange Act entitled for dividends, interest or proceeds from the sale or exercise of the
Rule 15a-6. For avoidance of doubt, RHB reiterates that it has not appointed any U.S. subject company’s securities covered in this report*;
broker-dealer during the issuance of this report. This report is confidential and not b) Being bound by an agreement to purchase securities or has the right to
intended for distribution to, or use by, persons other than the recipient and its transfer the securities or has the right to pre subscribe the securities*.
employees, agents and advisors, as applicable. Additionally, where research is c) Being bound or required to buy the remaining securities that are not
distributed via Electronic Service Provider, the analysts whose names appear in this subscribed/placed out pursuant to an Initial Public Offering*.
report are not registered or qualified as research analysts in the United States and are d) Managing or jointly with other parties managing such parties as referred to in
not associated persons of any registered U.S. broker-dealer as appointed by RHB (a), (b) or (c) above.
from time to time and therefore may not be subject to any applicable restrictions under 2. PT RHB Sekuritas Indonesia is not a market maker in the securities or capital
Financial Industry Regulatory Authority (“FINRA”) rules on communications with a market products of the subject company(ies) covered in this report.
subject company, public appearances and personal trading. Investing in any non-U.S. 3. None of PT RHB Sekuritas Indonesia’s staff** or associated person serve as a
securities or related financial instruments discussed in this research report may director or board member* of the subject company(ies) covered in this report.
present certain risks. The securities of non-U.S. issuers may not be registered with, or 4. PT RHB Sekuritas Indonesia did not receive compensation for investment banking
be subject to the regulations of, the U.S. Securities and Exchange Commission. or corporate finance services from the subject company in the past 12 months.
Information on non-U.S. securities or related financial instruments may be limited. 5. PT RHB Sekuritas Indonesia** did not receive compensation or benefit (including
Foreign companies may not be subject to audit and reporting standards and regulatory gift and special cost arrangement e.g. company/issuer-sponsored and paid trip) in
requirements comparable to those in the United States. The financial instruments relation to the production of this report:
discussed in this report may not be suitable for all investors. Transactions in foreign Notes:
markets may be subject to regulations that differ from or offer less protection than *The overall disclosure is limited to information pertaining to PT RHB Sekuritas
those in the United States. Indonesia only.
**The disclosure is limited to Research staff of PT RHB Sekuritas Indonesia only.
DISCLOSURE OF CONFLICTS OF INTEREST
Singapore
RHB Investment Bank Berhad, its subsidiaries (including its regional offices) and Save as disclosed in the following link RHB Research conflict disclosures – Dec 2021
associated companies, (“RHBIB Group”) form a diversified financial group, and to the best of our knowledge, the Singapore Research department of RHB Bank
undertaking various investment banking activities which include, amongst others, Berhad (through its Singapore branch) hereby declares that:
underwriting, securities trading, market making and corporate finance advisory. 1. RHB Bank Berhad, its subsidiaries and/or associated companies do not make a
market in any issuer covered by the Singapore research analysts in this report.
As a result of the same, in the ordinary course of its business, any member of the 2. RHB Bank Berhad, its subsidiaries and/or its associated companies and its
RHBIB Group, may, from time to time, have business relationships with, hold any analysts do not have a financial interest (including a shareholding of 1% or more)
positions in the securities and/or capital market products (including but not limited to in the issuer covered by the Singapore research analysts in this report.
shares, warrants, and/or derivatives), trade or otherwise effect transactions for its own 3. RHB Bank Berhad’s Singapore research staff or connected persons do not serve
account or the account of its customers or perform and/or solicit investment, advisory on the board or trustee positions of the issuer covered by the Singapore research
or other services from any of the subject company(ies) covered in this research report. analysts in this report.
4. RHB Bank Berhad, its subsidiaries and/or its associated companies do not have
While the RHBIB Group will ensure that there are sufficient information barriers and and have not within the last 12 months had any corporate finance advisory
internal controls in place where necessary, to prevent/manage any conflicts of interest relationship with the issuer covered by the Singapore research analysts in this
to ensure the independence of this report, investors should also be aware that such report or any other relationship that may create a potential conflict of interest.
conflict of interest may exist in view of the investment banking activities undertaken by 5. RHB Bank Berhad’s Singapore research analysts, or person associated or
the RHBIB Group as mentioned above and should exercise their own judgement connected to it do not have any interest in the acquisition or disposal of, the
before making any investment decisions. securities, specified securities based derivatives contracts or units in a collective
investment scheme covered by the Singapore research analysts in this report.
In Singapore, investment research activities are conducted under RHB Bank Berhad 6. RHB Bank Berhad’s Singapore research analysts do not receive any
(through its Singapore branch), and the disclaimers above similarly apply. compensation or benefit in connection with the production of this research report
or recommendation on the issuer covered by the Singapore research analysts.
Malaysia
Save as disclosed in the following link RHB Research conflict disclosures – Dec 2021 Analyst Certification
and to the best of our knowledge, RHBIB hereby declares that: The analyst(s) who prepared this report, and their associates hereby, certify that:
7
(1) they do not have any financial interest in the securities or other capital market
products of the subject companies mentioned in this report, except for:
Analyst Company
- -
(2) no part of his or her compensation was, is or will be directly or indirectly related to
the specific recommendations or views expressed in this report.
BANGKOK SINGAPORE
RHB Securities (Thailand) PCL RHB Bank Berhad (Singapore branch)
10th Floor, Sathorn Square Office Tower 90 Cecil Street
98, North Sathorn Road, Silom #04-00 RHB Bank Building
Bangrak, Bangkok 10500 Singapore 069531
Thailand Fax: +65 6509 0470
Tel: +66 2088 9999
Fax :+66 2088 9799